[go: up one dir, main page]

HK1100352A1 - Solid medicament of oral administration and preparation thereof - Google Patents

Solid medicament of oral administration and preparation thereof

Info

Publication number
HK1100352A1
HK1100352A1 HK07108113.8A HK07108113A HK1100352A1 HK 1100352 A1 HK1100352 A1 HK 1100352A1 HK 07108113 A HK07108113 A HK 07108113A HK 1100352 A1 HK1100352 A1 HK 1100352A1
Authority
HK
Hong Kong
Prior art keywords
preparation
oral administration
solid medicament
medicament
solid
Prior art date
Application number
HK07108113.8A
Inventor
Setsuo Namiki
Minoru Okada
Misao Murata
Tetsuo Kaneko
Original Assignee
Ssp Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ssp Co Ltd filed Critical Ssp Co Ltd
Publication of HK1100352A1 publication Critical patent/HK1100352A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK07108113.8A 2005-11-09 2007-07-26 Solid medicament of oral administration and preparation thereof HK1100352A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005324968A JP2007131561A (en) 2005-11-09 2005-11-09 Oral solid preparation and method for producing the same

Publications (1)

Publication Number Publication Date
HK1100352A1 true HK1100352A1 (en) 2007-09-21

Family

ID=38074929

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07108113.8A HK1100352A1 (en) 2005-11-09 2007-07-26 Solid medicament of oral administration and preparation thereof

Country Status (4)

Country Link
JP (1) JP2007131561A (en)
KR (1) KR20070049962A (en)
CN (1) CN1965836B (en)
HK (1) HK1100352A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103108557B (en) * 2010-07-09 2015-11-25 三得利食品饮料株式会社 Soda containing caffeine
JP2012095616A (en) * 2010-11-04 2012-05-24 Kao Corp Bitterness inhibitor
JP6161594B2 (en) * 2012-03-23 2017-07-12 大正製薬株式会社 soda drink
JP6554839B2 (en) * 2014-04-02 2019-08-07 大正製薬株式会社 Oral composition
CN105249439A (en) * 2015-11-10 2016-01-20 朱丽芬 Sticky powdered sugar having antioxidant function
HUE056233T2 (en) * 2015-11-18 2022-02-28 Hermes Pharma Gmbh Ibuprofen compositions for direct oral administration
WO2019063465A1 (en) * 2017-09-29 2019-04-04 Nestec S.A. Caffeine production method
HUE062682T2 (en) * 2018-11-16 2023-11-28 Ssp Co Ltd Ibuprofen-containing oral pharmaceutical formulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09208458A (en) * 1996-02-02 1997-08-12 Ss Pharmaceut Co Ltd Formulation with unpleasant taste masked
US5904937A (en) * 1997-10-03 1999-05-18 Fmc Corporation Taste masked pharmaceutical compositions
JPH11193230A (en) * 1997-12-26 1999-07-21 Takeda Chem Ind Ltd Controlled-release preparation
JP5248733B2 (en) * 2003-11-28 2013-07-31 エスエス製薬株式会社 Volatilization-preventing solid preparation and method for producing the same

Also Published As

Publication number Publication date
CN1965836B (en) 2011-02-02
JP2007131561A (en) 2007-05-31
CN1965836A (en) 2007-05-23
KR20070049962A (en) 2007-05-14

Similar Documents

Publication Publication Date Title
EP1919288A4 (en) Medicaments containing famotidine and ibuprofen and administration of same
IL221770A (en) Adamantyl-acetamide derivatives, pharmaceutical compositions comprising same and use thereof for preparation of medicaments
HK1119951A1 (en) Methods and compositions for oral administration of proteins
ZA200605631B (en) Directly compressible pharmaceutical composition for the oral administration of CCI-779
IL184735A0 (en) Pharmaceutical formulations and methods of use
IL184758A0 (en) New pharmaceutical compositions useful in the transmucosal administration of drugs
ZA200900345B (en) Preparation of pharmaceutical formulations
IL239868A0 (en) Capsule formulation of pirfenidone and pharmaceutically acceptable excipients
IL193762A (en) Compounds useful in inhibiting dgat1-related disorders, pharmaceutical compositions comprising them and use thereof in preparation of medicaments
ZA200900423B (en) Methods and medicaments for administration of ibuprofen
PL2308566T3 (en) Use of orally administered probiotic bifidobacteria for human beauty benefits
HK1100352A1 (en) Solid medicament of oral administration and preparation thereof
IL178067A0 (en) Pharmaceutical dosage forms and compositions
IL195931A0 (en) Pharmaceutical preparation for oral administration with controlled active ingredient release in the small intestine and methods for its production
ZA200801575B (en) Pharmaceutical formulations/composition of guanfacine suitable for single dose form administration daily
IL202111A0 (en) Formulations for the oral administration of therapeutic agents and related methods
EP1757273A4 (en) Preparation for oral administration
EP2196463A4 (en) Preparation of 5,6-dimethylxanthone-4-acetic acid, the derivatives prepared and pharmaceutical formulations thereof
IL179697A0 (en) Variants of unc5h2, their preparation and pharmaceutical compositions containing them
EP1855647A4 (en) Delayed release pharmaceutical oral dosage form and method of making same
PL1655026T3 (en) Solid pharmaceutical formulations comprising diacereine and meloxicam
IL191922A0 (en) Pharmaceutical formulations of oxcarbazepine and methods for its preparation
IL189827A0 (en) Pharmaceutical dosage forms and compositions comprising lecoztan
IL177751A0 (en) Pharmaceutical composition of (+)-erythro-mefloquine and its use
IL196358A0 (en) An oral pharmaceutical composition of an anilinopyrimidine, its preparation and use thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20151108